Article Information
History
- February 21, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Thibaut Coustillet1,
- Xavier Coumoul1,
- Anne-Sophie Villégier2,3,
- Michèle Bisson4,
- Ellen Fritsche5,6,7,
- Jean-Marc Brignon2,
- Florence Zeman2,3,† and
- Karine Audouze1,*,†
- 1Université Paris Cité, INSERM UMR-S 1124 T3S, 45 rue des Saints-Pères, 75006, Paris, FRANCE
- 2Institut National de l’Environnement Industriel et des Risques (INERIS), Unité Toxicologie Expérimentale et Modélisation (TEAM), Parc ALATA BP2, 60550, Verneuil-en-Halatte, FRANCE
- 3PériTox, UMR_I 01, CURS, Université de Picardie Jules Verne, Chemin du Thil, 80025, Amiens, FRANCE
- 4Unité d’Expertise en Toxicologie/Ecotoxicologie des Substances, Institut National de l’Environnement Industriel et des Risques, 60550, Verneuil-en-Halatte, FRANCE
- 5IUF – Leibniz Research Institute for Environmental Medicine, Duesseldorf, GERMANY
- 6Medical Faculty, Heinrich-Heine-University, Duesseldorf, GERMANY
- 7DNTOX GmbH, Duesseldorf, GERMANY
- ↵*Correspondence to: Karine Audouze, Université Paris Cité, INSERM UMR-S 1124 T3S, 45 rue des Saints-Pères, 75006, Paris, France. Email: karine.audouze{at}u-paris.fr
↵† These authors contributed equally to this work.
Posted February 21, 2024.
The Cost Outcome Pathway Framework: Integrating socio-economic impacts to Adverse Outcome Pathways
